497 related articles for article (PubMed ID: 8353882)
21. Liposome-bound prostaglandin E1 often prevents cyclic flow variations in stenosed and endothelium-injured canine coronary arteries.
Willerson JT; Yao SK; McNatt J; Cui K; Anderson HV; Swensen C; Ostro M; Buja LM
Circulation; 1994 Apr; 89(4):1786-91. PubMed ID: 8149544
[TBL] [Abstract][Full Text] [Related]
22. Induction of tissue factor in the arterial wall during recurrent thrombus formation.
D'Andrea D; Ravera M; Golino P; Rosica A; De Felice M; Ragni M; Cirillo P; Vigorito F; Corcione N; Tommasini P; Gargiulo A; Piro O; Calabró P; Chiariello M
Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1684-9. PubMed ID: 12869352
[TBL] [Abstract][Full Text] [Related]
23. Effect of aspirin on local prostaglandin production and serotonin accumulation in a canine model with coronary cyclic flow variations or thrombosis.
Yao SK; Benedict CR; Rosolowsky M; McNatt J; Falinska B; Campbell WB; Buja LM; Willerson JT
J Mol Cell Cardiol; 1991 Apr; 23(4):473-82. PubMed ID: 1942081
[TBL] [Abstract][Full Text] [Related]
24. Cyclic blood flow variations induced by platelet-activating factor in stenosed canine coronary arteries despite inhibition of thromboxane synthetase, serotonin receptors, and alpha-adrenergic receptors.
Apprill P; Schmitz JM; Campbell WB; Tilton G; Ashton J; Raheja S; Buja LM; Willerson JT
Circulation; 1985 Aug; 72(2):397-405. PubMed ID: 2988822
[TBL] [Abstract][Full Text] [Related]
25. Cell adhesion by membrane-bound paf-acether.
Ninio E; Leyravaud S; Bidault J; Jurgens P; Benveniste J
Int Immunol; 1991 Nov; 3(11):1157-63. PubMed ID: 1760410
[TBL] [Abstract][Full Text] [Related]
26. Platelet-activating factor and cerebral vasospasm following subarachnoid hemorrhage.
Hirashima Y; Endo S; Otsuji T; Karasawa K; Nojima S; Takaku A
J Neurosurg; 1993 Apr; 78(4):592-7. PubMed ID: 8450333
[TBL] [Abstract][Full Text] [Related]
27. [The role of platelet activating factor in pathogenesis of acute pancreatitis in dogs].
Ji Z; Wang B; Li S
Zhonghua Wai Ke Za Zhi; 1997 Feb; 35(2):108-10. PubMed ID: 10374489
[TBL] [Abstract][Full Text] [Related]
28. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
Baroggi N; Etienne A; Braquet P
Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108
[TBL] [Abstract][Full Text] [Related]
29. Role of platelet activating factor in kidney transplant rejection in the rat.
Butterly DW; Spurney RF; Ruiz P; Pirotzky E; Braquet P; Coffman TM
Kidney Int; 1995 Aug; 48(2):337-43. PubMed ID: 7564100
[TBL] [Abstract][Full Text] [Related]
30. Platelet-activating factor (PAF) inhibitory profile of KO-286011 on blood platelets in vitro and in vivo.
Ostermann G; Hofmann B; Kertscher HP; Till U
Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec; 342(6):713-8. PubMed ID: 2096302
[TBL] [Abstract][Full Text] [Related]
31. Endothelium-derived relaxing factor modulates platelet aggregation in an in vivo model of recurrent platelet activation.
Golino P; Cappelli-Bigazzi M; Ambrosio G; Ragni M; Russolillo E; Condorelli M; Chiariello M
Circ Res; 1992 Dec; 71(6):1447-56. PubMed ID: 1423938
[TBL] [Abstract][Full Text] [Related]
32. [Effect of BN52021 on platelet activating factor induced aggregation of psoriatic polymorphonuclear neutrophils].
Liu BJ; Zhang HT; Zheng MR
Zhonghua Yi Xue Za Zhi; 1994 Jun; 74(6):370-2, 392. PubMed ID: 7994650
[TBL] [Abstract][Full Text] [Related]
33. Effect of ginkgolide PAF-acether antagonists on arterial thrombosis.
Bourgain RH; Andries R; Braquet P
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():815-7. PubMed ID: 2960196
[TBL] [Abstract][Full Text] [Related]
34. Effects of PAF antagonist, BN52021, on the PAF-, methacholine-, and allergen-induced bronchoconstriction in asthmatic children.
Hsieh KH
Chest; 1991 Apr; 99(4):877-82. PubMed ID: 2009789
[TBL] [Abstract][Full Text] [Related]
35. Cyclic flow variations in a conscious dog model of coronary artery stenosis and endothelial injury correlate with acute ischemic heart disease syndromes in humans.
Ikeda H; Koga Y; Kuwano K; Nakayama H; Ueno T; Yoshida N; Adachi K; Park IS; Toshima H
J Am Coll Cardiol; 1993 Mar; 21(4):1008-17. PubMed ID: 8450149
[TBL] [Abstract][Full Text] [Related]
36. Evidence for a role of platelet activating factor in the pathogenesis of irreversible but not reversible myocardial injury after reperfusion in dogs.
Maruyama M; Farber NE; Vercellotti GM; Jacob HS; Gross GJ
Am Heart J; 1990 Sep; 120(3):510-20. PubMed ID: 2389687
[TBL] [Abstract][Full Text] [Related]
37. Role of platelet-activating factor (PAF) in platelet accumulation in rabbit skin: effect of the novel long-acting PAF antagonist, UK-74,505.
Pons F; Rossi AG; Norman KE; Williams TJ; Nourshargh S
Br J Pharmacol; 1993 May; 109(1):234-42. PubMed ID: 8495241
[TBL] [Abstract][Full Text] [Related]
38. Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis.
Przyklenk K; Kloner RA
Cardiovasc Res; 1993 Jun; 27(6):925-34. PubMed ID: 8221780
[TBL] [Abstract][Full Text] [Related]
39. Effect of aspirin and epinephrine on experimentally induced thrombogenesis in dogs. A parallelism between in vivo and ex vivo thrombosis models.
Roux SP; Sakariassen KS; Turitto VT; Baumgartner HR
Arterioscler Thromb; 1991; 11(5):1182-91. PubMed ID: 1911705
[TBL] [Abstract][Full Text] [Related]
40. Effect of platelet activating factor antagonists on cultured rat mesangial cells.
Neuwirth R; Singhal P; Satriano JA; Braquet P; Schlondorff D
J Pharmacol Exp Ther; 1987 Nov; 243(2):409-14. PubMed ID: 3119816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
